Visual Function Tests as Potential Biomarkers in Age-Related Macular Degeneration
Investigative Ophthalmology & Visual Science2011Vol. 52(13), pp. 9457–9457
Citations Over TimeTop 10% of 2011 papers
Peter Dimitrov, Liubov D. Robman, Mary Varsamidis, Khin Zaw Aung, Galina Makeyeva, Robyn H. Guymer, Algis J. Vingrys
Abstract
All the visual function tests had good diagnostic capacity. Combination of the 14-Hz flicker thresholds and dynamics of the PSR test provided optimal quantitative assessment of retinal function in early AMD, suggesting that this set is a potentially useful clinical tool for following progression of early AMD and assessing the efficacy of interventions.
Related Papers
- → INTRAVITREAL RANIBIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH GOOD BASELINE VISUAL ACUITY(2012)25 cited
- → RANIBIZUMAB AND AFLIBERCEPT FOR THE TREATMENT OF PIGMENT EPITHELIAL DETACHMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION(2017)9 cited
- → Anti-VEGF therapy for age-related macular degeneration(2018)5 cited
- → Subretinal Fluid Resolution and Visual Acuity in Patients with Neovascular Age-Related Macular Degeneration(2022)5 cited
- [Intravitreal ranibizumab for age-related macular degeneration].(2010)